The authorization of medicinal products makes part of those processes that the citizens take for granted, but it is crucial for this kind of agencies to keep their independence always and ever. The agency’s clients are the pharmaceutical industry companies, who pay for the procedure, but they do not have to control also the outcome of the assessments, therefore the agency shall ensure that its recommendations are made independently and do not create conflicts of interests. Digitilisation is an ongoing process that needs to be accelerated and transparency will certainly benefit of an increased attention to this dimension. I supported its discharge also this year.